ENDOCRINEDIRECT Trademark

Trademark Overview

On Saturday, February 19, 2022, a trademark application was filed for ENDOCRINEDIRECT with the United States Patent and Trademark Office. The USPTO has given the ENDOCRINEDIRECT trademark a serial number of 97275379. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, September 4, 2024. This trademark is owned by The Endocrine Society. The ENDOCRINEDIRECT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing online information in the fields of endocrinology, health and medicine
endocrinedirect

General Information

Serial Number97275379
Word MarkENDOCRINEDIRECT
Filing DateSaturday, February 19, 2022
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Pseudo MarkENDOCRINE DIRECT
Goods and ServicesProviding online information in the fields of endocrinology, health and medicine

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 8, 2022
Primary Code044
First Use Anywhere DateSunday, October 24, 2021
First Use In Commerce DateSunday, October 24, 2021

Trademark Owner History

Party NameThe Endocrine Society
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20036
Party NameThe Endocrine Society
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20036

Trademark Events

Event DateEvent Description
Wednesday, February 23, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 5, 2022ASSIGNED TO EXAMINER
Thursday, December 8, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 8, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2022EXAMINER'S AMENDMENT ENTERED
Friday, December 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 31, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 24, 2023USE AMENDMENT FILED
Thursday, August 24, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 10, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, October 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 4, 2024ASSIGNED TO LIE
Friday, January 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

endocrinedirect health medicine endocrinology fields online information providing